Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study
Annals of Hematology · 19.05.2026 · 105 (8)
DOI: 10.1007/s00277-026-07072-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 19.05.2026. Verfasst von Nicolas Thomas Iannozzi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Chromosomes, Human, Pair 1, Chromosome Aberrations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Parma.
Abstract (Originalsprache)
The presence of chromosome 1 abnormalities in multiple myeloma (MM) has been included in the more recent prognostic staging system; however, the prognostic role of chromosome 1 abnormalities remains controversial. Thus, in this study we have investigated the prognostic role of chromosome 1 abnormalities in a cohort of newly diagnosed MM (NDMM), performing a retrospective monocentric analysis of 95 patients. Median follow up was 66 months for overall survival (OS) and progression free survival (PFS), and 55 months for time to next treatment (TTNT). Univariate analyses showed that 1q gain or amplification did not significantly affect outcomes (OS p =0.30; PFS p =0.69; TTNT p =0.91). Conversely, del(1p) was associated with inferior OS ( p =0.015), PFS ( p =0.007), and TTNT ( p =0.038), although this effect did not persist in multivariable models. Notably, the co occurrence of del(1p) and del(17p) identified a subgroup with markedly worse prognosis across all endpoints and represented the only combination with a consistent additive adverse effect. Multivariable analyses confirmed that patients harboring both abnormalities had significantly poorer outcomes, including reduced OS (HR 6.97, 95% CI 2.94–16.54), PFS (HR 6.92, 95% confidence interval [CI] 2.89–16.55), and TTNT (HR 5.21, 95% CI 1.69–16.05. In conclusion, our study suggests that among the cytogenetic abnormalities, del(1p) is a significant negative prognostic factor in NDMM patients in combination with the presence of del(17p), in shaping the prognosis of NDMM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy.
- Hematology and BMT Unit, "Azienda Ospedaliero-Universitaria di Parma", Parma, Italy.
- Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy. nicola.giuliani@unipr.it.
- Hematology and BMT Unit, "Azienda Ospedaliero-Universitaria di Parma", Parma, Italy. nicola.giuliani@unipr.it.
- Department of Onco-Hematology-Multiple Myeloma and Monoclonal Gammopathies Program, "Azienda Ospedaliero-Universitaria di Parma", Parma, Italy. nicola.giuliani@unipr.it.
Förderung
- Università degli Studi di Parma
Zitieren
APA
Iannozzi, N. T., Sammarelli, G., Poletti, A., Todaro, G., Bernardi, M., Scita, M., Palma, A. B. D., Raimondi, V., Lungu, O., Carboni, E., Ricci, S., Sitzia, C., Dessena, M., Vescovini, R., Toscani, D., Storti, P., & Giuliani, N. (2026). Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study. Annals of Hematology, 105(8). https://doi.org/10.1007/s00277-026-07072-3
Vancouver
Iannozzi NT, Sammarelli G, Poletti A, Todaro G, Bernardi M, Scita M, et al. Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study. Annals of Hematology. 2026;105(8). doi:10.1007/s00277-026-07072-3
BibTeX
@article{Iannozzi2026,
author = {Iannozzi, Nicolas Thomas and Sammarelli, Gabriella and Poletti, Andrea and Todaro, Giannalisa and Bernardi, Matia and Scita, Matteo and Palma, Anna Benedetta Dalla and Raimondi, Vincenzo and Lungu, Oxana and Carboni, Eleonora and Ricci, Stefania and Sitzia, Camilla and Dessena, Mattia and Vescovini, Rosanna and Toscani, Denise and Storti, Paola and Giuliani, Nicola},
title = {Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {8},
doi = {10.1007/s00277-026-07072-3}
}
EUVIMED